Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- efocipegtrutideHM15211Phase 21 trial
Hanmi Pharmaceutical Company Limited · NASH - Nonalcoholic Steatohepatitis
- EG-301Phase 21 trial
Evergreen Therapeutics, Inc. · Non-Exudative (Dry) Age-related Macular Degeneration (dAMD)
- EG-501EG-MNTP-01Phase 21 trial
Evergreen Therapeutics, Inc. · Neuropsychiatric Systemic Lupus Erythematosus, Systemic Lupus Erythematosus (SLE), Cognitive Impairment
- EG-70Phase 21 trial
enGene, Inc. · Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Non-muscle Invasive Bladder Cancer
- EGEN-5784Genetically Engineered Porcine Liver, xenogeneic porcine liverPhase 21 trial
eGenesis, INC · Acute on Chronic Liver Failure (ACLF), Hepatic Encephalopathy (HE)
- EGL-001Phase 21 trial
Egle Therapeutics · Solid Tumor, Adult
- EHT102Phase 21 trial
Shanghai Euhearing Therapeutics Co., Ltd · Treatment of Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)
- EI-001Phase 21 trial
Elixiron Immunotherapeutics (Hong Kong) Ltd. · Non-segmental Vitiligo
- EI-1071Phase 21 trial
Elixiron Immunotherapeutics Inc. · Mild, Moderate, or Severe Alzheimer's Disease
- EIK1004-001IMP1707-001Phase 21 trial
Eikon Therapeutics · Advanced Solid Tumors
- EIK1005Phase 21 trial
Eikon Therapeutics · Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors, MSI-H/dMMR Gastric Cancer
- EIS-12656Phase 21 trial
Eisbach Bio GmbH · Advanced Solid Tumor, Homologous Recombination Deficiency, HRR Deficiency
- EL219Phase 21 trial
Elion Therapeutics, Inc. · Invasive Mould Infection
- ELE-101Phase 21 trial
Eleusis Therapeutics · Healthy Volunteers, Major Depressive Disorder, Depression
- ElezanumabABT-555Phase 21 trial
AbbVie · Spinal Cord Injury (SCI)
- ELU42Phase 21 trial
Eluciderm Inc · Diabetic Foot Ulcer, Wagner Grade 1 - 2, Chronic Wound
- ELV001Phase 21 trial
Elevara Medicines Limited · Active Rheumatoid Arthritis
- EMB07Phase 21 trial
Shanghai EpimAb Biotherapeutics Co., Ltd. · Combination Therapy, Aggressive B-Cell Non-Hodgkin Lymphoma, EMB07
- EMP-01Phase 21 trial
atai Therapeutics, Inc. · Social Anxiety Disorder
- ENA-001Phase 21 trial
Enalare Therapeutics Inc. · Respiratory Depression
- ENN0403Phase 21 trial
EnnovaBio · Diabetic Macular Edema (DME)
- ENP-501Phase 21 trial
N-Fold, LLC · Peanut Allergy
- enpulimabPhase 21 trial
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Advanced Solid Tumor
- ENV-101taladegibPhase 21 trial
Endeavor Biomedicines, Inc. · Idiopathic Pulmonary Fibrosis, Progressive Fibrosing Interstitial Lung Disease
- ENV-501Phase 21 trial
Hummingbird Bioscience · Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer
- EO2463Phase 21 trial
Enterome · Follicular Lymphoma, Marginal Zone Lymphoma
- EP-104GIPhase 21 trial
Eupraxia Pharmaceuticals Inc. · Eosinophilic Esophagitis
- EP0031Phase 21 trial
Ellipses Pharma · NSCLC
- EP0042Phase 21 trial
Ellipses Pharma · Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes
- EP0062Phase 21 trial
Ellipses Pharma · Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer
- EP0089-101Phase 21 trial
Ellipses Pharma · Solid Cancers, Solid Tumours
- epacadostatPhase 21 trial
Incyte · Endometrial Cancer
- EPI-001Phase 21 trial
Epibiotech · Androgenetic Alopecia
- EPI-321Phase 21 trial
Epicrispr Biotechnologies, Inc. · Facioscapulohumeral Muscular Dystrophy
- Eque-celFully Human BCMA Chimeric Antigen Receptor Autologous T CellPhase 21 trial
Nanjing IASO Biotechnology Co., Ltd. · Relapsed/Refractory Multiple Myeloma
- ER2001Phase 21 trial
ExoRNA Bioscience · Huntington Disease
- ERAS-0015Phase 21 trial
Tango Therapeutics, Inc. · PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC
- ERAS-601Phase 21 trial
Erasca, Inc. · Advanced or Metastatic Solid Tumors
- ERX1000Phase 21 trial
ERX Pharmaceuticals · Obesity & Overweight
- ES014Phase 21 trial
Elpiscience (Suzhou) Biopharma, Ltd. · Desmoid Tumor
- ES102Phase 21 trial
Elpiscience (Suzhou) Biopharma, Ltd. · Non-Small Cell Lung Cancer
- ETD001Phase 21 trial
Enterprise Therapeutics Ltd · Cystic Fibrosis
- ETH47Phase 21 trial
Ethris GmbH · Asthma (Diagnosis)
- ETX-19477Phase 21 trial
858 Therapeutics, Inc. · Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer
- ETX-636Phase 21 trial
Ensem Therapeutics · Advanced Solid Tumors, Advanced Breast Cancer
- ETX-929Phase 21 trial
Ensem Therapeutics · Metastatic Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Non-squamous, Non-Small Cell Lung Cancer
- EvalstotugBA3071Phase 21 trial
BioAtla, Inc. · Head and Neck Cancer, Squamous Cell Carcinoma of Head and Neck, Recurrent Squamous Cell Carcinoma of the Head and Neck
- EVER001Phase 21 trial
Everest Medicines (China) Co.,Ltd. · Minimal Change Disease (MCD), IgA Nephropathy (IgAN), Focal Segmental Glomerulosclerosis (FSGS)
- EvexomostatSDX-7320Phase 21 trial
SynDevRx, Inc. · HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer
- EVM14Phase 21 trial
Everest Medicines (Beijing) Co., Ltd. · Selected Types of Solid Tumor
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.